Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Nuevos derivados de carbamato activos en el sistema nervioso central como medicamento antiepiléptico

Resumen

Tipo:
Demanda Tecnológica
Referencia:
TRKR20190529001
Publicado:
25/06/2019
Caducidad:
25/06/2020
Resumen:
Una empresa coreana fundada en 1978 es la principal compañía del mercado doméstico con el mayor rendimiento en el campo de neuropsicología. La empresa ha producido más de 80 tipos de medicamentos para el tratamiento de la esquizofrenia, tranquilizantes, antidepresivos, fármacos antiepilépticos y medicamentos para el tratamiento de la enfermedad hepática alcohólica. Su objetivo es buscar derivados de carbamato activos en el sistema nervioso central (SNC) como medicamento antiepiléptico. La tecnología buscada debe presentar una actividad anticonvulsiva similar a la compatibilidad electromagnética racémica en ratones y ratas. La empresa busca socios con el fin de desarrollar los medicamentos y establecer acuerdos de comercialización con asistencia técnica y licencia para entrar en mercados internacionales.

Details

Tittle:
New CNS-active carbamate derivatives as anti-epileptic drug
Summary:
A Korean company established in 1978 has been No. 1 domestric company with highest yield in the field of neuropsychology. Thus, the company has produced more than 80 types of medicines for treatment of Schizopherenia, tranquilizer, antidepressant, anti-epileptic drugs, and treatment of alcoholic disease. The company is seeking for partners to develop the medicines and enter the international market under commercial agreement with technical assistance and license agreement.
Description:
A Korean company has focused on the psychiatric and neurological disease since founded in 1978, and they developed approximately 80 types of medicines including neuro-psychology therapy.
The company is seeking for technology called new CNS (Central Nervous System) active carbamate derivatives as anti-epileptic drug. The technology needs a function that it shows similar activity of anti-convulsant to racemic EMC (Electromagnetic Compatibility) in mouse and rat.
Basically, the company is thinking about active anticonvulsant with various spectrum that would be triggered prior to activity of mechanism.
With these ideas, the company is open for two cooperation types, such as license and commercial agreement with technical asisstance with partners to research in the field of pharmaceuticals.
Technical Specification or Expertise Sought:
The Korean SME is seeking fro experts to cooperate with development in technology for innovative efficiency on neuropsychology therapy.

Partner sought

Type and Role of Partner Sought:
- Type of partner sought: SME or Research Institute
- Specific area of activity of the partner: Pharmaceuticals, Alzheimer´s treatment
- Task to be performed: Technology of CNS (Central Nervous System) should be developed to functions as pharmacetical drugs for neuro-psychology therapy with partnership of commercial agreement with technical assistance and license agreement.

Client

Type and Size of Client:
Industry 250-499
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English